Table 4.
Disease Status
| Dose of Melphalan | Disease Status at Transplantation | Disease Status at 100 Days | Disease Status at 1 Year |
|---|---|---|---|
| 140 | PD | SD | PR |
| 140 | VGPR | SD | SD |
| 140 | VGPR | SD | BMT |
| 160 | CR | CR | CR |
| 160 | PR | SD | CR |
| 160 | CR | CR | REL |
| 180 | PD | CR | CR |
| 180 | CR | CR | CR |
| 180 | PR | BMT | BMT |
| 200 | CR | REL | CR |
| 200 | PD | EXP | EXP |
| 200 | PR | PD | VGPR |
| 180 | PD | PR | PD |
| 180 | PD | PR | X |
| 180 | VGPR | VGPR | X |
PD indicates progressive disease; SD, stable disease; PR, partial response; VGPR, very good partial response; BMT, bone marrow transplant; CR, complete response; REL, Relapse; EXP, deceased.
Response and progression in this study were evaluated using the Southwest Oncology Group (SWOG) criteria for Multiple Myeloma staging.